Modifiable comorbidities impact on ventral hernia recurrence following robotic abdominal wall reconstruction using resorbable biosynthetic mesh: 36-month follow-up

BACKGROUND: There is an ongoing debate on the role of comorbidities in hernia outcomes, particularly with minimally invasive approaches. This study evaluated the impact of modifiable comorbidities (MCMs) on 36-month hernia recurrence rates after robotic transversus abdominis release (TAR) with resor...

Descripción completa

Detalles Bibliográficos
Autores principales: Skoczek, Alexandra C., Ruane, Patrick W., Fernandez, Dennis L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392596/
https://www.ncbi.nlm.nih.gov/pubmed/37533880
http://dx.doi.org/10.1016/j.sopen.2023.07.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392596/
https://www.ncbi.nlm.nih.gov/pubmed/37533880
http://dx.doi.org/10.1016/j.sopen.2023.07.012

Ejemplares similares